BioPharm America 2014 EBD Group MassBio Image Map
Share:
Email this page Share this on LinkedIn Share this on Twitter

BioPharm America™ 2015 Press Releases

News for BioPharm America™ 2015 will be available soon.

October 2, 2014Record number of licensing opportunities presented at BioPharm America™ 2014 International Life Science Partnering Event in Boston The seventh annual BioPharm America international life science partnering conference wrapped up last week, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event was attended by close to 900 high-level delegates representing 511 companies from 38 countries who engaged in 2,343 one-to-one partnering meetings with 787 lice...  more ►

September 22, 2014FierceBiotech's 2014 "Fierce 15" Announced Today at BioPharm America™ 2014International Life Science Partnering Event in Boston
The seventh annual BioPharm America international life science partnering conference kicked off today in Boston with the live announcement of the biotech's most daring characters in biopharma, the "Fierce 15," by John Carroll, Editor-in-Chief of FierceBiotech. "It's always a lot of fun to look over a new group of Fierce 15 companies," said John Carroll, Editor-in-Chief, of ...  more ►

September 8, 2014BioPharm America™ 2014 leads off with Fierce 15 Announcement and Keynote Address featuring Chief Scientific Officer from Sanofi The seventh annual BioPharm America international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The highly reputable life science partnering event will draw biotech and pharma executives from around the world to identify and enter into strategic r...  more ►

August 19, 2014Renewed investor appetite in biotech innovation means strong attendance expected at BioPharm America™ 2014 The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event is a big draw for pharma and investors who want to access innovative new potential therapies and cures brought by international biotech companies. "Today is a great time...  more ►

May 20, 2014Collaborative models and IPO window are hot topics at BioPharm America™ 2014 program The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings together industry thought leaders and high level executives in the biopharma dealmaking arena to collaborate on and discuss relevant trends and topics. Several i...  more ►

April 15, 2014BioPharm America™ 2014 returns to Boston's Copley Place and a celebration of the FierceBiotech Fierce 15 The seventh annual BioPharm America international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston's historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

December 9, 2014 Interview with Dan Zhang, Foundation Medical Development partneringNEWS recently spoke with Dan Zhang, CEO of Fountain Medical Development, a CRO based mainly in China, but also with offices in the US, Taiwan, Hong Kong and South Korea. With China being the second largest healthcare market in the world, Zhang talks about the incentives for global companies to do business in China, and the ways in which FMD facilitates that. more ►

November 11, 2014 Bayer committed to Open Innovation and Collaborators The Head of Global Drug Discovery at Bayer HealthCare and a Member of the Executive Committee, Andreas Busch described the strategy underlying partnering efforts that he said have delivered a very significant value to patients as well as to shareholders. more ►

November 11, 2014 Merck Serono embraces partnering in all its forms Executive VP and Head of Global Research and Development at Merck Serono, Luciano Rossetti is also a Member of the Executive Committee who joined the company in late July this year. He offered to share with the audience a perspective from what he called a brief tenure. more ►

November 11, 2014 European biotech poised for acceleration David Loew is Senior VP for Commercial Operations in Europe at Sanofi. Rather than focusing on the company, Loew turned the spotlight on a wider concern for promoting a stronger environment for biotechs and start-ups in Europe. more ►

November 11, 2014 Transformational deals that shaped the industry in 2014 Led by moderator David Stubbs, the Managing Director for Inverness Advisors, the goal for the panel was to provide insights for transformational deals of the past year. The session was led off by a truly transformational deal that saw the USD 14.2 billion divestiture by Merck of its consumer healthcare business to Bayer HealthCare in May, 2014. The deal makes Bayer the second-biggest over-the-counter drug maker behind Johnson & Johnson. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
BioPharm America 2014 EBD Group MassBio Image Map